Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

anticonvulsant/crise épileptique

Le lien est enregistré dans le presse-papiers
Page 1 de 62 résultats

Anticonvulsant composition and method

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention relates to a group of novel compositions containing diphenylhydantoin and/or dextromethorphan or another compound that binds to the same sites in the brain as dextromethorphan, with substantially the same or higher affinity. Another aspect of this invention

Anticonvulsant and central nervous system-depressing bis(fluorophenyl)alkylamides and their uses

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to compounds useful in treating pathological conditions, such as convulsions and spasticity, without producing undesirable excessive sedation or muscle weakness in animal subjects, including humans. More particularly, the invention relates to the

Method for treating convulsions and epilepsy with organic copper compounds

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds. BACKGROUND OF THE INVENTION Copper is a normal component of the human brain, which contains

Method for treating convulsions and epilepsy with organic copper compounds

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds. BACKGROUND OF THE INVENTION Copper is a normal component of the human brain, which contains

Method for treating convulsions and epilepsy with organic copper compounds

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to a method of convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds. BACKGROUND OF THE INVENTION Copper is a normal component of the human brain, which contains about 370 mg

Method for treating convulsions and epilepsy with organic copper compounds

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to a method of treating convulsions, including convulsive tremors and convulsive seizures, and, in particular, epilepsy, with organic copper compounds. BACKGROUND OF THE INVENTION Copper is a normal component of the human brain, which contains

Anticonvulsive agents and uses thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION The present invention relates to a agents useful as excitatory amino acid antagonists. The quinoline and kynurenin derivatives of the present invention have affinity for the glycine binding site of the NMDA receptor. Compounds of the present invention should be usable for

2-aryl-3-heterocyclicmethyl-3H-imidazo[4,5-b]pyridines as anxiolytics and anticonvulsants

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION The present invention relates to certain novel imidazo[4,5-b]pyridines useful as anxiolytic and anticonvulsant agents, by virtue of their ability to bind to the benzodiazepine receptors and inhibit electrically or chemically induced seizures. The preparation of fused

Cis-N-(2-aminocycloaliphatic)benzamide anti-convulsants

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
INTRODUCTION This invention relates the use of certain N-(2-amino-cycloaliphatic)benzamide compounds as Central Nervous System (CNS) antiseizure, e.g., anti-convulsant, drugs in valuable warm-blooded animals, including humans. BACKGROUND OF THE INVENTION Szmuszkovicz U.S. Pat. No. 4,098,904

Compositions and methods for treating or preventing convulsions or seizures

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to compositions and methods for treating or preventing convulsions or seizures. BACKGROUND OF THE INVENTION Tofisopam is 1-(3,4-dimethoxy-phenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiaze- pine, which can be represented by the

Compositions and methods for treating or preventing convulsions or seizures

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION The present invention relates to compositions and methods for treating or preventing convulsions or seizures. BACKGROUND OF THE INVENTION Tofisopam is 1-(3,4-dimethoxy-phenyl)-4-methyl-5-ethyl-7,8-dimethoxy-5H-2,3-benzodiazep ine, which can be represented by the formula:

Use of statins as anticonvulsants, antiepileptics and neuroprotectors

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS-REFERENCE TO RELATED APPLICATIONS This application is filed under the provisions of 35 U.S.C. .sctn.371 and claims the priority of International Patent Application No. PCT/ES2009/070201 filed on 3 Jun. 2009 entitled "Use of Statins as Anticonvulsants, Antiepileptics and Neuroprotectors" in the

Anticonvulsant drugs and pharmaceutical compositions thereof

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to new anticonvulsants drugs and pharmaceutical compositions containing the anticonvulsants drugs and methods of treating with the drugs. 2. Description of Related Art GABA is an inhibitory neurotransmitter which

1-phenylalkanecarboxylic acid derivatives as anticonvulsant and neuroprotective agents

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION This invention pertains to a group of compounds which exhibit surprising anticonvulsant and neuroprotective properties, and methods for their use in controlling seizures or convulsions. The compounds are 1-phenylalkanecarboxylic acid derivatives. The invention is also directed

5-phenyl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants

Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
More specifically this invention relates to compounds of the formula ##STR1## and the tautomers thereof, wherein R.sub.1 is hydrogen of C.sub.1-4 lower alkyl, R.sub.2 is C.sub.1-4 lower alkyl, R is halogeno or trifluoromethyl, and n is zero, 1 or 2. For R, preferably halogeno represents chloro or
Rejoignez notre
page facebook

La base de données d'herbes médicinales la plus complète soutenue par la science

  • Fonctionne en 55 langues
  • Cures à base de plantes soutenues par la science
  • Reconnaissance des herbes par image
  • Carte GPS interactive - étiquetez les herbes sur place (à venir)
  • Lisez les publications scientifiques liées à votre recherche
  • Rechercher les herbes médicinales par leurs effets
  • Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets

Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées

Google Play badgeApp Store badge